GGLClass II
Control, White-Cell
21 CFR 864.8625 / Hematology
GGL is the FDA product code for Control, White-Cell, a class II device type, regulated under 21 CFR 864.8625. As of , FDA records hold 8 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- GGL
- Device name
- Control, White-Cell
- Regulation
- 21 CFR 864.8625
- Device class
- Class II
- Review panel
- Hematology
- Submission type
- 510(k) exempt
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 8
- Ingested recalls
- 0
Clearances, product code GGL
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1989 | 2 |
| 1992 | 1 |
| 1994 | 1 |
| 1996 | 1 |
| 1999 | 1 |
| 2005 | 1 |
| 2009 | 1 |
Applicants with the most clearances
Product code GGL| Applicant | Clearances |
|---|---|
| Streck Laboratories, Inc. | 4 |
| Streck LLC | 2 |
| Coulter Corp. | 1 |
| Elite Diagnostic, Ltd. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
